HARVARD BIOSCIENCE INC's ticker is HBIO and the CUSIP is 416906105. A total of 100 filers reported holding HARVARD BIOSCIENCE INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $489,000 | -52.3% | 89,472 | -62.6% | 0.39% | +79.2% |
| Q4 2020 | $1,026,000 | -62.5% | 239,106 | -73.7% | 0.22% | -51.7% |
| Q3 2020 | $2,739,000 | -46.7% | 909,977 | -45.2% | 0.45% | -11.7% |
| Q2 2020 | $5,143,000 | +43.7% | 1,659,141 | +2.5% | 0.51% | +35.3% |
| Q1 2020 | $3,579,000 | -25.5% | 1,619,393 | +2.9% | 0.37% | +14.0% |
| Q4 2019 | $4,801,000 | +13.7% | 1,573,981 | +14.6% | 0.33% | +13.5% |
| Q3 2019 | $4,224,000 | +82.8% | 1,373,518 | +18.9% | 0.29% | +50.5% |
| Q2 2019 | $2,311,000 | +506.6% | 1,155,376 | +1207.4% | 0.19% | +500.0% |
| Q1 2019 | $381,000 | – | 88,369 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Harvey Partners, LLC | 1,020,036 | $7,120,000 | 5.32% |
| Portolan Capital Management | 2,358,010 | $16,459,000 | 1.20% |
| Acuitas Investments, LLC | 375,836 | $2,623,000 | 1.14% |
| Parkman Healthcare Partners LLC | 475,367 | $3,318,000 | 0.84% |
| Adirondack Research & Management Inc. | 90,020 | $628,000 | 0.76% |
| Archon Capital Management LLC | 736,236 | $5,139,000 | 0.73% |
| BARD ASSOCIATES INC | 294,697 | $2,057,000 | 0.70% |
| PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. | 1,621,775 | $11,320,000 | 0.65% |
| GLOBEFLEX CAPITAL L P | 268,466 | $1,874,000 | 0.41% |
| Monarch Partners Asset Management LLC | 330,083 | $2,304,000 | 0.34% |